Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

Pages

35 results
4:46 PM, Jul 13, 2017  |  BC Week In Review | Company News  |  Sales & Marketing

ASCO recommends MammaPrint to inform chemo use

of the MammaPrint test to identify women who need chemotherapy and those who do not. Agendia N.V.
test for women with HER2-positive or triple-negative breast cancers (see BioCentury, Sept. 5, 2016 ). Agendia
12:00 AM, Oct 13, 2014  |  BC Week In Review | Company News  |  Management Tracks

Agendia management update

Agendia N.V. , Amsterdam, the Netherlands   Business: Diagnostic, Microarrays   Hired: Jan Egberts, a director, as …
12:00 AM, May 05, 2014  |  BC Week In Review | Company News  |  Deals

Agendia, Daiichi Sankyo deal

Agendia will use undisclosed cancer biomarkers to assess patient samples in trials of undisclosed Daiichi products …
Agendia develops and markets formalin-fixed paraffin-embedded (FFPE) genomic diagnostics. The partners declined to disclose details. Agendia N.V.
12:00 AM, Jun 10, 2013  |  BC Week In Review | Company News  |  Management Tracks

Agendia management update

Agendia B.V. , Amsterdam, the Netherlands   Business: Diagnostic, Microarrays   Hired: Peter Schineller as chief …
12:00 AM, Feb 04, 2013  |  BC Week In Review | Company News  |  Management Tracks

Agendia management update

Agendia B.V. , Amsterdam, the Netherlands   Business: Diagnostic, Microarrays   Hired: Neil Barth as CMO …
12:00 AM, Jul 16, 2012  |  BC Week In Review | Company News  |  Management Tracks

Agendia management update

Agendia B.V. , Amsterdam, the Netherlands   Business: Diagnostic, Microarrays   Hired: Glen Fredenberg as CFO …
12:00 AM, Jun 11, 2012  |  BC Week In Review | Company News  |  Sales & Marketing

Agendia sales and marketing update

Agendia launched its colon cancer recurrence test ColoPrint for stage II colon cancer prognosis and prediction …
ColoPrint is a microarray-based 18-gene expression profile. Agendia B.V. , Amsterdam, the Netherlands   Business: Diagnostic …
12:00 AM, Jan 16, 2012  |  BC Week In Review | Company News  |  Management Tracks

Agendia management update

Agendia B.V. , Amsterdam, the Netherlands   Business: Diagnostic, Microarrays   Hired: Peter Wulff as VP …
12:00 AM, Dec 12, 2011  |  BC Week In Review | Company News  |  Sales & Marketing

Agendia sales and marketing update

Agendia launched a formalin fixed paraffin embedded (FFPE) format for its Symphony breast cancer assays. Agendia
12:00 AM, Oct 31, 2011  |  BC Week In Review | Company News  |  Management Tracks

Agendia management update

Agendia B.V. , Amsterdam, the Netherlands   Business: Diagnostic, Microarray   Transitioned: David Macdonald to CEO …

Pages